When John Lechleiter took the reins of Eli Lilly & Co. back in 2008, the outlook was not very rosy for the Indianapolis-based company. Tasked with leading the company’s 41,000 employees through what he terms the “Y/Z period” [the years 2011-2014 where patent losses punctuated the big pharma's financial performance], he had to create solid strategies that would guide the company back to its glory days.
Lechleiter had already worked for Lilly since 1979, beginning his career as an organic chemist before winding his way around...
